Body composition phenotypes in rheumatoid arthritis
https://doi.org/10.33667/2078-5631-2020-31-5-8
Abstract
Objective. To study body composition phenotypes, the frequency of osteoporosis (OP), sarcopenia (SP), and obesity in postmenopausal women with rheumatoid arthritis (RA).
Material and methods. 99 women (aged 40-75 years) with RA were enrolled in the study. All patients were interviewed using a special questionnaire. Anthropometric measurements and muscle strength determination were also peiformed. Bone mineral density and body composition were assessed with dual energy X-ray absorptiometry.
Results. The frequency of OP was 31.3 % and the confirmed SP was 21.2 %. Isolated osteopenic phenotype was found in 14.1 %, osteosarcopenia - in 6.1 %, isolated sarcopenic phenotype - in 2.0 %, and phenotypes with obesity (osteopenic obesity, osteosarcopenic obesity and isolated obesity) - in 70.7 % of patients. Only 7.1 % of women had healthy phenotype.
Conclusion. Patients with RA had combined phenotypes of body composition more often than isolated ones. Phenotypes with obesity determined by densitometry were the most common.
About the Authors
O. V. Dobrovolskaya
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
O. A. Nikitinskaya
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
A. O. Efremova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
N. V. Dyomin
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
N. V. Toroptsova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
А. Yu. Feklistov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Moscow
References
1. Konis J, McCloskey E, Johansson H, et al. Development and use of FRAX® in osteoporosis. Osteoporosis International. 2010; 21 (S2): 407-413. DOI: 10.1007/s00198-010-1253-y.
2. Diaz BB, Gonzalez DA, Gannar F, et al. Myokines, physical activity, insulin resistance and autoimmune diseases. Immunology Letters, 2018; 203: 1-5. DOI: 10.1016/j.imlet.2018.09.002.
3. Stavropoulos-Kalinoglou A, Metsios G, Koutedakis Y et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007; 66 (10): 1316-1321. DOI: 10.1136/ard.2006.060319.
4. С. Е. Мясоедова, О. А. Рубцова, Е. Е. Мясоедова. Композиционный состав тела и минеральная плотность кости у женщин при ревматоидном артрите. Клиницист, 2016; 10 (3): 41-45. DOI: 10.17650/1818-8338-2016-10-3-41-45.
5. Book C, Karlsson M, Akesson K, Jacobsson L. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol. 2008; 37 (4): 248-54. DOI: 10.1080/03009740801998747.
6. Heberlein I, Demary W, Bloching H, Braun J, Buttgereit F, Dreher R, Kuhn C, Lange U, Pollahne W, Zink A, Zeidler H, Hantzschel H, Raspe H. Medikamentose Osteoporoseprophylaxe und -Therapie bei Pati-enten mit Rheumatoider Arthritis (ORA-Studie) [Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)]. Z Rheumatol. 2011; 70 (9): 793-8, 800-2. German. DOI: 10.1007/s00393-011-0872-9.
7. Hamalainen H, Kautiainen H, Kaarela K, Kotaniemi A. The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2005; 23 (2): 193-8. PMID: 15895889.
8. Barone M, Viggiani MT, Anelli MG, et al. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. Journal of Clinical Medicine, 2018; 7 (12): 504. DOI: 10.3390/jcm7120504.
9. Giles JT, Ling SM, Ferrucci L et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum, 2008; 59: 807-815.
10. Torii M, Hashimoto M, Hanai A, et al. Prevalence and factors associated with sarcope-nia in patients with rheumatoid arthritis. Modern Rheumatology, 2019; 29 (4): 589-595. DOI: 10.1080/14397595.2018.1510565.
11. Ngeuleu A, Allali F, et al. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatology International, 2017; 37 (6): 1015-1020. DOI: 10.1007/s00296-017-3665-x.
12. Guimaraes MF, da Costa Pinto MR, Raid RG, et al. Which is the best cutoff of body mass index to identify obesity in female patients with rheumatoid arthritis? A study using dual energy X-ray absorptiometry body composition. Rev Bras Reumatol. 2017; 57 (4): 279-285. DOI: 10.1016/j.rbr.2015.09.008.
13. Tello-Winniczuk N, Vega-Morales D, Garcia-Her-nandez PA, et al. Value of body mass index in the diagnosis of obesity according to DEXA in well-controlled RA patients. Reumatol Clin. 2017; 13 (1): 17-20. DOI: 10.1016/j.reuma.2016.02.003.
14. Hars M, Biver E, Chevalley T et al. Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees. Journal of Bone and Mineral Research. 2016; 31 (11): 2048-2056. DOI: 10.1002/jbmr.2878.
Review
For citations:
Dobrovolskaya O.V., Nikitinskaya O.A., Efremova A.O., Dyomin N.V., Toroptsova N.V., Feklistov А.Yu. Body composition phenotypes in rheumatoid arthritis. Medical alphabet. 2020;(31):5-8. (In Russ.) https://doi.org/10.33667/2078-5631-2020-31-5-8
Views:
359
Email this article 